1. Home
  2. SANG vs NNNN Comparison

SANG vs NNNN Comparison

Compare SANG & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sangoma Technologies Corporation

SANG

Sangoma Technologies Corporation

HOLD

Current Price

$4.66

Market Cap

157.1M

Sector

Technology

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$3.80

Market Cap

163.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SANG
NNNN
Founded
1984
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
157.1M
163.7M
IPO Year
2018
2023

Fundamental Metrics

Financial Performance
Metric
SANG
NNNN
Price
$4.66
$3.80
Analyst Decision
Hold
Analyst Count
4
0
Target Price
★ $5.54
N/A
AVG Volume (30 Days)
★ 127.9K
46.5K
Earning Date
11-13-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.23
N/A
Revenue Next Year
$0.96
N/A
P/E Ratio
★ N/A
$446.57
Revenue Growth
N/A
N/A
52 Week Low
$3.40
$3.09
52 Week High
$5.42
$44.73

Technical Indicators

Market Signals
Indicator
SANG
NNNN
Relative Strength Index (RSI) 58.43 33.42
Support Level $4.64 $3.09
Resistance Level $5.02 $6.95
Average True Range (ATR) 0.11 0.45
MACD -0.05 0.10
Stochastic Oscillator 44.74 39.17

Price Performance

Historical Comparison
SANG
NNNN

About SANG Sangoma Technologies Corporation

Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic location USA and Other countries. Key revenue is generated from USA.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Share on Social Networks: